Point72 Asset Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Point72 Asset Management’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-40,890	Closed	-$4.72M	–	1139
2017 Q3	$4.72M	Buy	+40,890	New	+$4.3M	0.02%	546
2016 Q1	–	Sell	-16,640	Closed	-$3.37M	–	889
2015 Q4	$3.37M	Buy	+16,640	New	+$2.98M	0.03%	474
2015 Q3	–	Sell	-50,520	Closed	-$10.7M	–	932
2015 Q2	$10.7M	Buy	50,520 +13,710	+37%	+$3.36M	0.07%	308
2015 Q1	$8.53M	Buy	36,810 +17,610	+92%	+$4.26M	0.06%	354
2014 Q4	$4.42M	Buy	+19,200	New	+$4.12M	0.03%	455

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management's BLCM Position: Q4 2017 in Review

Point72 Asset Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2017, closing a stake of 40,890 shares — an estimated $4.72M sold.

Point72 Asset Management first reported a position in BLCM in Q4 2014 and held it in 5 quarters. The position peaked at $10.7M in Q2 2015. 91 funds tracked by Wall St. Rank hold BLCM as of Q4 2017.

Point72 Asset Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Point72 Asset Management sold 40,890 Bellicum Pharmaceuticals, Inc. shares in Q4 2017, an estimated $4.72M.
Point72 Asset Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 5 quarters.
Point72 Asset Management's Bellicum Pharmaceuticals, Inc. position peaked at $10.7M in Q2 2015.
91 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2017.

Based on Point72 Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.